Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Building an Apple-Like Healthcare Experience—featuring Diogo Rau

There’s a lot of fear around applying artificial intelligence to the life sciences.  And while Diogo Rau concedes that there are risks associated with using AI, the biggest risk is that we won’t use it. Diogo Rau is EVP and Chief Information and Digital Officer of <a href="https://www.lilly.com/" target="_blank">Eli Lilly &amp; Company</a>, where he leads their information technology, cybersecurity, digital health, advanced analytics and data science functions.  Prior to joining Lilly, Diogo served as Head of Engineering for Apple Retail and Partner at McKinsey &amp; Company. On this episode of HLTH Matters, Diogo joins host Dr. Gautam Gulati to discuss the use of AI to facilitate clinical trials and drug discovery in a patient-first world. Diogo explains how he is bringing Apple’s focus on the end user to life sciences, sharing his vision of what an Apple-like healthcare experience looks like and how to create a culture of innovation at Lilly. Listen in for Diogo’s insight on using tech to inspire behavior change in patients and learn how we might leverage AI to generate new medicines, improve clinical trials and facilitate personalized medicine. Topics Covered<ul><li>How Diogo is bringing Apple’s focus on the end user to life sciences</li><li>Diogo’s take on what differentiates customers from patients</li><li>What inspired Diogo’s transition from Apple to his current role at Lilly</li><li>Leveraging artificial intelligence to facilitate personalized medicine</li><li>Why Lilly is prioritizing AI-designed and generated medicines</li><li>How to discern when we can innovate fast in the life sciences space</li><li>Building a culture of innovation in a large company like Lilly</li><li>How Diogo thinks about Lilly’s role in the healthcare ecosystem</li><li>Diogo’s vision of what an Apple-like healthcare experience looks like</li><li>Using technology to facilitate prevention through behavior change</li><li>Why Lilly is working on both insulin drugs and diabetes prevention</li><li>Diogo’s mission to impact the way medicine gets to patients </li></ul> Connect with Diogo Rau<ul><li><a href="https://www.lilly.com/" target="_blank">Eli Lilly &amp; Company</a></li><li>Diogo on <a href="https://www.linkedin.com/in/diogo-rau-811217/" target="_blank">LinkedIn</a></li></ul> Connect with Dr. Jessica Shepherd &amp; Dr. Gautam Gulati<ul><li><a href="https://www.hlth.com/" target="_blank">HLTH</a></li><li>Dr. Shepherd on <a href="https://twitter.com/JShepherd_MD" target="_blank">X</a></li><li>Dr. Shepherd on <a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">LinkedIn</a></li><li>Dr. Gulati on <a href="https://twitter.com/drgautamgulati" target="_blank">X</a></li><li>Dr. Gulati on <a href="https://www.linkedin.com/in/gautamgulati/" target="_blank">LinkedIn</a></li></ul> Resources<ul><li><a href="https://hbr.org/2020/01/the-essential-clayton-christensen-articles" target="_blank">Clay Christensen’s Model of Disruptive Innovation</a></li><li><a href="https://jamesclear.com/atomic-habits" target="_blank">Atomic Habits by James Clear</a></li><li><a href="https://waitbutwhy.com/" target="_blank">Wait But Why Blog</a></li></ul>

S4 E27: Building an Apple-Like Healthcare Experience—featuring Diogo Rau

Executive Vice President and Chief Information and Digital Officer

Microsoft's Collaboration with Healthcare Leaders for Trustworthy AI

AI&#39;s potential to revolutionize healthcare requires a focus on responsible and trustworthy implementation. In this episode, Dr. David Rhew from Microsoft, along with Marcella Dalrymple and Dr. Michael Pencina from Duke Health, discuss the collaboration between Microsoft and Duke Health to explore the transformative potential of artificial intelligence (AI) in healthcare. Dr. Rhew emphasizes the importance of responsible and trustworthy AI, acknowledging its limitations and the need for operationalizing key principles. Dr. Pencina outlines four principles for trustworthy AI: prioritizing the human person, defining AI use cases, anticipating consequences, and establishing governance. Marcella Dalrymple, with her community perspective, highlights the necessity of addressing public uncertainty and mistrust regarding AI development. The partnership aims to form a Center of Excellence for trustworthy AI, focusing on collaborative efforts to align with ethical values and engage the community bidirectionally. The guests stress the importance of a robust governance system, automation for efficiency, and continuous monitoring to ensure AI&#39;s intended impact. Tune in and learn how this collaboration strives to revolutionize healthcare responsibly through AI! About David Rhew:Since August 2019, David has served as Chief Medical Officer &amp; VP of Healthcare for Microsoft&#39;s Worldwide Commercial Business (WCB). David and his team&#39;s main goal is to demonstrate how a large-scale data-driven approach can lead to smarter decision-making, more proactive care, and improved health outcomes, as well as lower costs for patients and populations. Additionally, David is an adjunct professor at the Department of Medicine, Division of Primary Care and Population Health at Stanford University. About Marcella Dalrymple:Marcella is the Associate Director of Strategic Development and Business Partnerships at Duke AI Health. Her goal is to operationalize novel ideas by using big data to achieve the most meaningful results, leading to improved clinical practices. Prior to that role, she was the Commercial Leadership Associate in the marketing sector for AstraZeneca and a project manager for Duke Clinical Research Institute. About Michael Pencina:Michael Pencina, PhD, is Duke Health&#39;s Chief Data Scientist and serves as Vice Dean for Data Science, Director of Duke AI Health, and Professor of Biostatistics and Bioinformatics at the Duke University School of Medicine. He develops and implements quantitative science strategies for the School of Medicine, co-chairs Duke Health’s Algorithm-Based Clinical Decision Support (ABCDS) Oversight Committee, and co-directs Duke’s Collaborative to Advance Clinical Health Equity (CACHE). Things You’ll Learn:<ul><li>AI&#39;s potential to revolutionize healthcare requires a focus on responsible and trustworthy implementation.</li><li>The collaboration between Microsoft and Duke Health aims to create a Center of Excellence for trustworthy AI.</li><li>The four principles for trustworthy AI are: prioritize the human person, define use cases, anticipate consequences, and establish governance.</li><li>Public mistrust of AI in healthcare highlights the need for community engagement and bidirectional communication.</li><li>Automation in governance processes can streamline AI integration and reduce friction in workflows.</li></ul>Resources:<ul><li>Connect with and follow David Rhew on <a href="https://www.linkedin.com/in/david-rhew-m-d-1832764/" target="_blank">LinkedIn</a>.</li><li>Follow Microsoft on <a href="https://www.linkedin.com/company/microsoft/" target="_blank">LinkedIn</a> and visit their <a href="https://news.microsoft.com/source/" target="_blank">website</a>.</li><li>Connect with and follow Marcella Dalrymple on <a href="https://www.linkedin.com/in/marcella-dalrymple-mphmba/" target="_blank">LinkedIn</a>.</li><li>Connect with and follow Michael Pencina on <a href="https://www.linkedin.com/in/michael-pencina-89194a42/" target="_blank">LinkedIn</a>.</li><li>Follow Duke Health AI on <a href="https://www.linkedin.com/company/duke-ai-health/" target="_blank">LinkedIn</a> and visit their <a href="https://aihealth.duke.edu/" target="_blank">website</a>.</li></ul>

S4 E32: Microsoft's Collaboration with Healthcare Leaders for Trustworthy AI

Global Chief Medical Officer, VP of Healthcare Worldwide Commercial

Chief Data Scientist for Duke Health; Vice Dean for Data Science; Director, Duke AI Health; Professor, Biostatistics & Bioinformatics; Duke University School of Medicine

Associate Director of Strategic Development and Business Partnerships

Leveraging Patient Voices to Inform Healthcare Policy—featuring Andy Slavitt

All too often, the people building healthcare solutions in the public sector have never seen a patient. The same goes for policymakers. And the voices of real people with real health problems get lost.  That’s why Andy Slavitt advocates for a collaborative approach to solving critical problems in healthcare. An approach that leverages the lived experiences of everyday Americans to inform innovation and policy. Andy is General Partner of <a href="https://www.townhallventures.com/" target="_blank">Town Hall Ventures</a>, a healthcare firm that invests in underrepresented communities, and Founder of <a href="https://unitedstatesofcare.org/" target="_blank">United States of Care</a>, a national nonprofit health advocacy organization. Andy has led many of the nation&#39;s most important healthcare initiatives, serving as President Obama&#39;s Head of Medicare and Medicaid and overseeing the turnaround, implementation, and defense of the Affordable Care Act. On this episode of HLTH Matters, Andy joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss the future of public-private partnerships to drive innovation and policy decision making. Andy explains why policy drives innovation in healthcare, exploring the obstacles to adopting effective policy on a national level and what prevents hospital systems from prioritizing prevention over treatment.  Listen in for insight on what inspired Andy’s work with underserved communities and learn how he finds companies building simple healthcare solutions and invests in helping them scale. Topics Covered<ul><li>The experiences that inspired Andy’s work to serve underrepresented communities</li><li>Why it’s so challenging to build effective healthcare policy in our political system</li><li>Andy’s approach to solving critical problems in healthcare through collaboration among innovators, policymakers and everyday citizens</li><li>The common attributes of companies Andy invests in through Town Hall Ventures</li><li>Why Andy believes that policy drives innovation in the healthcare space</li><li>The obstacles to adopting effective healthcare policy on a national level</li><li>What prevents hospital systems from prioritizing prevention over treatment</li><li>How Andy invests in companies building simple healthcare solutions and helps them scale (e.g.: urgent care centers for mental health crises)</li></ul> Connect with Andy Slavitt<a href="https://www.townhallventures.com/" target="_blank">Town Hall Ventures</a><a href="https://unitedstatesofcare.org/" target="_blank">United States of Care</a><a href="https://podcasts.apple.com/us/podcast/in-the-bubble-with-andy-slavitt/id1504128553" target="_blank">In the Bubble Podcast</a>Andy on <a href="https://twitter.com/ASlavitt" target="_blank">X</a> Connect with Dr. Jessica Shepherd &amp; Dr. Gautam Gulati<a href="https://www.hlth.com/" target="_blank">HLTH</a>Dr. Shepherd on <a href="https://twitter.com/JShepherd_MD" target="_blank">X</a>Dr. Shepherd on <a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">LinkedIn</a>Dr. Gulati on <a href="https://twitter.com/drgautamgulati" target="_blank">X</a>Dr. Gulati on <a href="https://www.linkedin.com/in/gautamgulati/" target="_blank">LinkedIn</a> Resources<a href="https://connectionshs.com/" target="_blank">Connections</a>

S4 E24: Leveraging Patient Voices to Inform Healthcare Policy—featuring Andy Slavitt

General Partner

The Future of Retail & Virtual Health—featuring Dr. Patrick Carroll

Millennials are acquiring chronic diseases at a younger age than any prior generation. But the way they access healthcare is fundamentally different from other demographics. Millennials prefer virtual visits with providers and prescription delivery to visiting a clinic or pharmacy—and that’s why the consumer retail health company hims &amp; hers is on an upward trajectory. Dr. Patrick Carroll is the Chief Medical Officer at <a href="https://www.forhims.com/" target="_blank">hims</a> &amp; <a href="https://www.forhers.com/" target="_blank">hers</a>, a telehealth platform that offers a modern approach to health and wellness, providing customers with easy-to-access virtual primary care. In his role as CMO, Dr. Carroll oversees clinical programs, quality assurance and healthcare collaborations. Prior to joining hims &amp; hers in 2019, Dr. Carroll served as CMO at Walgreens, and he is Board Certified in both family practice and adolescent medicine. On this episode of HLTH Matters, Dr. Carroll joins hosts Dr. Gautam Gulati and Dr. Jordan Shlain to discuss his transition from primary care physician to consumer-facing health and explain what inspired him to join the team at hims &amp; hers. Dr. Carroll describes how millennials access care in a fundamentally different way from their parents, offering insight into how hims &amp; hers’ customers benefit from the company’s subscription model and commitment to virtual primary care. Listen in to understand the regulatory and medical licensing challenges they face at hims &amp; hers and get Dr. Carroll’s take on the future of consumer retail and virtual health. Topics Covered <ul><li>How Dr. Carroll’s work on a Navajo reservation informed the rest of his career</li><li>Dr. Carroll’s transition from traditional primary care to retail and consumer-facing health</li><li>What inspired Dr. Carroll to take on the role of CMO at hims &amp; hers</li><li>How customers benefit from the hims &amp; hers’ subscription business model</li><li>The trend toward virtual primary care and why hims &amp; hers has no plans for brick-and-mortar locations</li><li>Why Dr. Carroll sees millennials as an underserved demographic</li><li>What constraints hims &amp; hers faces in terms of regulatory and medical licensing challenges</li><li>How the hims &amp; hers team works with states to advocate for asynchronous communication</li><li>How Dr. Carroll defines healthcare as any entity, technology or individual that helps a customer optimize their wellbeing</li><li>How millennials access healthcare in a fundamentally different way from their parents (and how that contributes to the success of hims &amp; hers)</li></ul> Connect with Dr. Patrick Carroll<a href="https://www.forhims.com/" target="_blank">hims</a><a href="https://www.forhers.com/" target="_blank">hers</a><a href="https://www.linkedin.com/in/patrick-carroll-a7b5a364/" target="_blank">Dr. Carroll on LinkedIn</a> Connect with Dr. Gautam Gulati &amp; Dr. Jordan Shlain<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter</a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn</a><a href="https://twitter.com/drshlain" target="_blank">Dr. Shlain on Twitter</a><a href="https://www.linkedin.com/in/drjordanshlain/" target="_blank">Dr. Shlain on LinkedIn</a> Resources<a href="https://www.ihs.gov/" target="_blank">Indian Health Service</a><a href="https://www.villagemd.com/" target="_blank">VillageMD</a><a href="https://goforward.com/" target="_blank">Forward Health</a><a href="https://www.americantelemed.org/" target="_blank">American Telemedicine Association</a><a href="https://ro.co/" target="_blank">Ro</a> Introductory Quote[6:05] “Really what fascinated me about what hims &amp; hers was doing—they reach a millennial and younger demographic that none of the health systems, the medical groups or even Walgreens ever reached, so I saw the opportunity as working in a space that was actually the front door to healthcare for millennials and younger.”

S2 Ep13: The Future of Retail & Virtual Health—featuring Dr. Patrick Carroll

Chief Medical Officer

Podcast

S4 E27: Building an Apple-Like Healthcare Experience—featuring Diogo Rau

FEATURING